| Bioactivity | Eprobemide is a non-competitive reversible inhibitor of monoamine oxidase A. | ||||||||||||
| Target | Monoamine oxidase A | ||||||||||||
| Invitro | Eprobemide is a pharmaceutical drug that is used as an antidepressant. Eprobemide is a non-competitive reversible inhibitor of monoamine oxidase A that exhibits selective action on serotonin deamination[1][2]. | ||||||||||||
| Name | Eprobemide | ||||||||||||
| CAS | 87940-60-1 | ||||||||||||
| Formula | C14H19ClN2O2 | ||||||||||||
| Molar Mass | 282.77 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Gol'dina OA, et al. The action of befol and its derivatives on monoamine oxidase of different origins. Biull Eksp Biol Med. 1991 Mar;111(3):279-80. [2]. Donskaya, et al. Antidepressant Befol Synthesized Via Interaction of 4-Chloro-N-(3-chloropropyl)benzamide with Morpholine. Pharmaceutical Chemistry Journal, 2004 Jun; 38(7): 381-384. |